determinant of the characteristics of resultant gliomas. [5] [6] [7] The Cre/ LoxP system affords the most powerful tool for this purpose, but requires complex and time-consuming breeding strategies when more than 2 genetic alterations are to be introduced. Somatic cell gene transfer provides an alternative strategy for this purpose. The
Sleeping Beauty (SB) transposable element has been used to transfer multiple DNA sequences into neural progenitor and stem cells (NPC). 8 Wiesner et al showed that the triple combination of NRAS-G12V, EGFRvIII, and shp53 induced gliomas with 100% efficiency and median survival was 83 days. The piggyBac transposon system has been used to induce glioma with HRAS and AKT mutations. 9, 10 One limitation of the existing transposon-based glioma models is that RAS mutations are rare in human gliomas; 3 thus, there is a need for a highly penetrant glioma mouse model that genetically mimics human gliomas.
Recent profiling of human gliomas by single-cell RNA-sequencing (RNA-seq) indicated previously unrecognized intratumoral heterogeneity in transcriptional programs. 11, 12 The cause of such diversity remains unclear; it is possible that different mutations harbored in individual cells, epigenetic states in tumor cells, and the tumor microenvironment may be responsible for the diversity. Interclonal cooperation between tumor subclones maintains tumor heterogeneity in mammary cancer, 13 but such cooperation has not been documented in glioma. To obtain a better understanding of the cause of intratumoral heterogeneity in glioma, mouse models that recapitulate the complex population dynamics of tumor subclones are needed.
Chen et al 10 In the present study, we developed a transposon vector encoding the triple combination of platelet-derived growth factor subunit A (PDGFA), and shRNAs against Nf1 and Trp53 (shp53/shNf1). PDGF signaling is a key regulator of oligodendrocyte development and for glioma. 14, 15 The PDGF family consists of covalently linked hetero-or homodimers of A-, B-, C-, and D-chains (PDGF-AA, -AB, -BB, -CC, and -DD). These ligands bind to heterodimeric a and b tyrosine kinase receptors and activate downstream signaling. PDGFA is expressed in approximately 81% of malignant gliomas. 16 PDGF-AA binds only to PDGF receptor alpha (PDGFR-a), which is encoded by PDGFRA. PDGFRA is amplified, mutated, or rearranged in a subset of human glioblastomas. [16] [17] [18] [19] The NF1 tumor suppressor gene is responsible for the genetically heritable disease neurofibromatosis type 1. 20 NF1 mutations are present in~10% of human glioblastomas. 3 In gliomagenesis, a gain of several copies of Chr 7 occurs in the early stage and is concurrent with PDGFA overexpression, followed by NF1 loss at the late stage. 21 The NF1 loss is associated with TP53 mutations. 22 Ozawa et al 21 modeled these mutations in mice using the RCAS/tv-a retroviral system, and showed that the triple combination of PDGFA, shNf1, and shp53 induced glioblastoma.
The initiation and progression of glioma in this model remain 
| Cell line experiments
Experiments with NIH3T3 cells were carried out as described previously. 26 Briefly 
| Primary culture of glioma cells
Tumors were dissociated and cultured in the serum-free medium as described previously. 27 
| Histology and tumor analysis
Perfusion fixation was carried out prior to dissection, and the brain was fixed in 4% paraformaldehyde (PFA). Brains were embedded in FSC22 compound (Leica). Brain sections (10 lm) were prepared by using a microtome (Leica). We used the DsRed-Express fluorescent protein, which has a short half-life (~12 hours), 28 and is well suited to monitoring the expression levels of PDGFA. The previously reported shRNAs were used for shNf1 and shp53. 7, 24, 27 The SB transposon system is composed of 2 elements: a transposon DNA substrate and the SB transposase enzyme. 29 The transposon DNA substrate can be delivered as a plasmid DNA to achieve chromosomal integration and long-term expression. The SB transposase was investigated to determine whether it Figure 3G ). GFP+ cells expressed Olig2 ( Figure 3H, arrows) , but the majority were EdU-negative, indicating that GFP+ cells were slowly cycling. Proliferative tumor-associated OPC were not observed ( Figure 3I , arrows).
| Immunohistochemistry
The number of GFP-negative OPC in the brain parenchyma was comparable between regions with or without GFP+ cells ( Figure 3J ).
These findings indicate that the NP vector induced slow growth of OPC, but these cells were not associated with proliferative tumorassociated OPC.
| Intratumoral heterogeneity developed spontaneously in tumors in P+NP mice
To investigate the mechanism by which PDGFA cooperated with shNf1/shp53, we co-electroporated the P and NP vectors (P+NP mice). Genomic integration of the P or NP vector induces the expression of DsRed or GFP, respectively. Clusters of transduced cells are visualized as "red" or "green" (Figure 4A ). Transfected cells that acquire genomic integrations of both P and NP vectors express both DsRed and GFP, visualized as "yellow" cells present within the cluster ( Figure 4A ). The expression levels of GFP and DsRed are variable; therefore, "red" and "green" cells may also be present within the cluster.
Histological analysis of the brain was carried out at 2 weeks post-electroporation, when transient gene expression was no longer present in dividing cells. The majority of "red" cells remained as a single cell (P clone) ( Figure 4B) ; clusters of "green" cells, which incorporated the NP vector (NP clone), were observed ( Figure 4C ).
"Green" cells occasionally incorporated EdU. Clusters containing "yellow" cells were observed, indicating that the cluster was derived from cells that incorporated both the P and NP vectors (P+NP clone) ( Figure 4D ). An abundance of EdU+ cells was observed in "yellow" Histological analysis of the brain of a P+NP mouse showed a large tumor mass at 10 weeks ( Figure 5A ). The center of the tumor consisted of "yellow" and "red" cells ( Figure 5A-c,d ). The peripheral region mainly consisted of "green" cells ( Figure 5A -a,b,e). "Yellow" or "red" cells were densely packed, whereas "green" cells showed dif- in glioma cells, and causes metabolic changes in glioma. 39 Hypoxic stress induces glioma cells to migrate away from hypoxic areas by promoting a mesenchymal shift. 40 As Nf1 loss converts glioma cells to the mesenchymal subtype, 21 glioma cells at the invasion front showed the Nf1 knockdown phenotype ("green" cells) rather than PDGFA upregulation ("yellow" or "red" cells). Intratumoral heterogeneity of PDGFA expression has not previously been reported in human gliomas, 16 
